5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 2.20▼ | 2.22▼ | 2.22▼ | 2.23▼ | 2.18▼ |
MA10 | 2.22▼ | 2.25▼ | 2.26▼ | 2.21▼ | 2.23▼ |
MA20 | 2.25▼ | 2.27▼ | 2.26▼ | 2.15▲ | 2.35▼ |
MA50 | 2.26▼ | 2.23▼ | 2.20▼ | 2.24▼ | 2.47▼ |
MA100 | 2.18▼ | 2.11▲ | 2.28▼ | 2.35▼ | 5.18▼ |
MA200 | 2.22▼ | 2.35▼ | 2.32▼ | 2.39▼ | 18.12▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.011▼ | -0.016▼ | -0.015▼ | 0.013▲ | 0.021▲ |
RSI | 38.768▼ | 38.306▼ | 41.462▼ | 47.141▼ | 46.308▼ |
STOCH | 20.899 | 28.534 | 22.292 | 58.249 | 39.360 |
WILL %R | -85.714▼ | -89.474▼ | -89.474▼ | -43.902 | -68.617 |
CCI | -128.333▼ | -176.376▼ | -203.989▼ | 0.771 | -23.493 |
Tuesday, May 27, 2025 09:35 PM
S UNNYVALE, Calif. - BioCardia (NASDAQ:BCDA), Inc. [Nasdaq: BCDA], a developer of cellular therapies for cardiovascular diseases with a current market capitalization of $12 million, has announced ...
|
Wednesday, May 14, 2025 08:16 PM
BioCardia Inc (NASDAQ:BCDA) reported positive safety and meaningful benefits from their cardiac cell therapy for heart failure patients, addressing a significant unmet clinical need. The company ...
|
Wednesday, May 14, 2025 01:32 AM
GEE Group (AMEX:JOB) is projected to report earnings for its second quarter. • BioCardia (NASDAQ:BCDA) is projected to report earnings for its first quarter. • Okeanis Eco Tankers (NYSE ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
13/06/25 | 2.1733 | 2.24 | 2.14 | 2.18 | 12,792 |
12/06/25 | 2.28 | 2.3399 | 2.1582 | 2.20 | 85,906 |
11/06/25 | 2.28 | 2.36 | 2.25 | 2.25 | 13,086 |
10/06/25 | 2.24 | 2.33 | 2.24 | 2.29 | 27,926 |
09/06/25 | 2.19 | 2.33 | 2.17 | 2.24 | 38,158 |
06/06/25 | 2.15 | 2.1878 | 2.10 | 2.1705 | 13,135 |
05/06/25 | 2.22 | 2.22 | 2.13 | 2.13 | 10,259 |
04/06/25 | 2.19 | 2.2591 | 2.14 | 2.17 | 31,519 |
03/06/25 | 2.26 | 2.29 | 2.18 | 2.18 | 29,288 |
02/06/25 | 2.21 | 2.3099 | 2.21 | 2.26 | 40,854 |
|
|
||||
|
|
||||
|
|